Heparin-coated equipment reduces the risk of oxygenator failure.

BACKGROUND The development of an abnormal pressure gradient (APG) across the oxygenator is the most common cause of oxygenator failure during cardiopulmonary bypass. This necessitated changing the oxygenator in 4 patients in this series. A retrospective analysis of conditions predisposing to APG was performed. METHODS One thousand nine hundred fifty-nine operations with cardiopulmonary bypass were performed in adults. A range of membrane oxygenators was used subject to availability; 769 oxygenators were heparin-coated and 1,190 were uncoated. The pressure gradient across the oxygenator was measured under standardized conditions. An APG was defined as a gradient of greater than twice the mean. RESULTS An APG occurred in 44 uncoated and 3 heparin-coated oxygenators (p < 0.001). The mean age was higher for the APG group (p < 0.001). Fibrin deposits in the arterial line filter were noted in 45 patients. Logistic regression revealed that only fibrin deposition in the arterial line filter and the use of uncoated oxygenators were significantly associated with APG. CONCLUSIONS We conclude that a heparin-coated oxygenator effectively prevents APG. This adds significantly to the safety of open heart operations.

[1]  S. Bannan,et al.  Low heparinization with heparin-bonded bypass circuits: is it a safe strategy? , 1997, The Annals of thoracic surgery.

[2]  K. Niwaya,et al.  Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. , 1996, Artificial organs.

[3]  M. Blombäck,et al.  Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass. , 1995, Journal of cardiothoracic and vascular anesthesia.

[4]  H. Wendel,et al.  Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  L. Edmunds.  Surface-bound heparin--panacea or peril? , 1994, The Annals of thoracic surgery.

[6]  E. Fosse,et al.  Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  E. Fosse,et al.  Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.

[8]  M. Pasic,et al.  Risk and benefit of low systemic heparinization during open heart operations. , 1994, The Annals of thoracic surgery.